What is the recommended treatment for sustained supraventricular arrhythmia?

Treatment for Sustained Supraventricular Arrhythmia

For hemodynamically stable patients with sustained SVT, start with vagal maneuvers immediately, followed by intravenous adenosine if vagal maneuvers fail; for hemodynamically unstable patients, proceed directly to synchronized cardioversion. 1

Acute Management Algorithm

Step 1: Assess Hemodynamic Stability

Determine if the patient has signs of hemodynamic instability (hypotension, altered mental status, chest pain, acute heart failure, or shock).

Step 2A: Hemodynamically Stable Patients

First-line interventions:

• Vagal maneuvers should be attempted first 1
  • Valsalva maneuver: Patient bears down against closed glottis for 10-30 seconds (equivalent to 30-40 mm Hg intrathoracic pressure) in supine position
  • Carotid sinus massage: Apply steady pressure over carotid sinus for 5-10 seconds after confirming absence of bruit
  • Ice-cold towel to face (diving reflex)
  • Success rate approximately 27.7% when switching between techniques

Second-line pharmacologic therapy:

• Adenosine is the drug of choice when vagal maneuvers fail 1
  • Terminates AVNRT in approximately 95% of patients
  • Also serves as diagnostic tool by unmasking atrial activity
  • Brief side effects occur in ~30% but last <1 minute

Third-line alternatives for stable patients:

• Intravenous diltiazem or verapamil are reasonable alternatives 1

  • Particularly effective for converting AVNRT to sinus rhythm
  • Success rates of 80-98% when combined with adenosine
  • Critical safety warning: Avoid in patients with VT, pre-excited AF, or systolic heart failure—can cause hemodynamic collapse and ventricular fibrillation

• Intravenous beta-blockers are reasonable but less effective than calcium channel blockers 1

  • Excellent safety profile
  • In head-to-head comparison, diltiazem was more effective than esmolol

Fourth-line option:

• Intravenous amiodarone may be considered when other therapies fail or are contraindicated 1
  • Effective but reserved for refractory cases
  • Short-term use avoids long-term toxicity concerns

Step 2B: Hemodynamically Unstable Patients

Immediate synchronized cardioversion is mandatory 1

• Do not delay for vagal maneuvers or medications if patient is unstable
• If adenosine or vagal maneuvers are already in progress and fail, proceed immediately to cardioversion
• Highly effective for terminating all forms of SVT (AVRT and AVNRT)

Step 3: If Pharmacologic Therapy Fails in Stable Patients

Synchronized cardioversion is recommended when medications are ineffective or contraindicated 1

• Success rates of 80-98% with initial pharmacologic therapy mean cardioversion is rarely needed in stable patients
• Consider second bolus or higher dose of initial agent before proceeding to cardioversion

Special Considerations and Pitfalls

Pre-excited Atrial Fibrillation

• Never use AV nodal blocking agents (adenosine, diltiazem, verapamil, beta-blockers) 1
• These can precipitate ventricular fibrillation by blocking the AV node and forcing conduction down the accessory pathway
• Use ibutilide or intravenous procainamide in stable patients 1
• Immediate cardioversion in unstable patients 1

Wide-QRS Tachycardia

• Ensure you are not dealing with VT before administering calcium channel blockers
• Adenosine has increased strength of recommendation for wide-QRS tachycardias in recent guidelines 2
• Procainamide and amiodarone have been downgraded for acute management 2

Ongoing/Long-term Management

• Oral verapamil or diltiazem recommended for patients not pursuing catheter ablation 1
• Monitor for bradyarrhythmias and hypotension when initiating therapy
• Avoid in systolic heart failure

Key Guideline Updates (2019 ESC)

The 2019 ESC guidelines 2 made significant changes from 2003:

• Adenosine consolidated as first-line pharmacologic therapy
• Verapamil and diltiazem downgraded for acute narrow-QRS tachycardias
• Amiodarone and digoxin no longer recommended for acute narrow-QRS management
• Beta-blockers downgraded across multiple SVT subtypes
• Catheter ablation significantly upgraded to preferential status for definitive management 3

The ACC/AHA/HRS 2015 guidelines 1 align closely with this algorithmic approach, emphasizing the vagal maneuvers → adenosine → cardioversion sequence for most SVTs.